Article Source : 한국경제Link : https://www.hankyung.com/article/202309147941i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202308296231i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202308231428i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202308148513i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202308016446i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202306214781i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202304289604i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202304200337i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202304184914i
Article Source : 머니투데이Link : https://news.mt.co.kr/mtview.php?no=2023040314334967730
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202303162439i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202303159193i
Article Source : 한국경제Link : https://www.hankyung.com/it/article/202302033591i
Article Source : PR NewswireLink : https://www.prnewswire.com/news-releases/qurient-co-ltd-and-tb-alliance-announce-exclusive-license-agreement-for-telacebec-q203-a-new-anti-tuberculosis-agent-301738149.html
Article Source : 바이오스펙테이터Link : http://www.biospectator.com/view/news_view.php?varAtcId=18181